U.S. Regulators: Some Theranos Tests 'Pose Immediate Jeopardy To Patient Health And Safety'

A scathing letter from the Centers for Medicare and Medicaid Services poses a new threat to the blood testing startup following warnings from the FDA. More than ever, Theranos needs to present data showing that its technology works.